Key Metrics
CiteScore 

30.8
Eigenfactor 

0.001 - 0.005
H-Index 

125
Impact Factor 

20 - 25
SJR 

Q1Oncology

SNIP 

3.67
Recommended pre-submission checks
Powered by 

Topics Covered on Drug Resistance Updates
Drug Resistance Updates Journal Specifications
| Overview | |
| Publisher | CHURCHILL LIVINGSTONE |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1998 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Drug Resistance Updates ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Drug Resistance Updates
Lactate-driven H3K18 lactylation promotes cisplatin resistance in bladder cancer via HNRNPF-Parkin mediated mitophagy.
- 1 Sep 2026
- Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Biomimetic delivery systems for overcoming drug resistance in gastrointestinal cancers.
- 6 Aug 2026
- Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
ITPKB suppresses ER calcium release to promote CXCL9 expression and enhance immunotherapy sensitivity in triple-negative breast cancer.
- 2 Aug 2026
- Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Targeting a novel metabolic vulnerability of non-small cell lung cancer to fatty acid oxidation surmounts chemoresistance.
- 2 Aug 2026
- Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
MZF1-mediated GAPDH overexpression drives glycolytic reprogramming and neuroendocrine progression in advanced prostate cancer.
- 1 Aug 2026
- Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Protein SUMOylation confers sorafenib resistance in human hepatocellular carcinoma via the induction of PKM2-mediated glycolysis.
- 16 Jul 2026
- Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Lactate-driven H3K18 lactylation promotes cisplatin resistance in bladder cancer via HNRNPF-Parkin mediated mitophagy.
- 1 Sep 2026
- Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Biomimetic delivery systems for overcoming drug resistance in gastrointestinal cancers.
- 6 Aug 2026
- Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
ITPKB suppresses ER calcium release to promote CXCL9 expression and enhance immunotherapy sensitivity in triple-negative breast cancer.
- 2 Aug 2026
- Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Targeting a novel metabolic vulnerability of non-small cell lung cancer to fatty acid oxidation surmounts chemoresistance.
- 2 Aug 2026
- Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
MZF1-mediated GAPDH overexpression drives glycolytic reprogramming and neuroendocrine progression in advanced prostate cancer.
- 1 Aug 2026
- Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Protein SUMOylation confers sorafenib resistance in human hepatocellular carcinoma via the induction of PKM2-mediated glycolysis.
- 16 Jul 2026
- Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy